Fortis expanding the number of beds: Rajesh Jain, Market Strategist

Rajesh Jain, Market Strategist, in a chat with ET Now talks about the pharma and healthcare space.

Talking about Lupin, Apollo Hospitals, do you like any of these counters?

I like the healthcare space and Apollo Hospitals and Fortis Healthcare have been working on two very focussed strategies. The first is an expansion of the number of beds that they have in the country. Both of them have been expanding vigorously to tier 1 towns in addition to the metros. If you look at the development yesterday that has been there in the Fortis Group, they have also ventured out and bought diagnostics, clinics chain outside the country. So that is showing a sustained effort to grow the global footprint. The healthcare space - despite the long gestation period and a slower velocity of returns - is one place where if you take three year kind of horizon, then there is multi-bagger gains to be made.

Lupin continues to be one of the leading Indian pharma stocks which has two very strong triggers. One is the international marketing tie-up that they have both abroad and in India and the other is the sustained focus on R&D that has driven the bottom line of this company for the last 18 months or so. That would continue to be a driver in that stock.